Become a member for only $5
Automatically entered for complimentary FBI in your area!
DermDetect has developed a new and improved method of skin cancer screening that is way better than free!
DermDetect has joined with the Oregon Health & Science University (OHSU) Knight Cancer Institute to advance skin cancer research as part of research collaboration. With your OHSU consent, you can donate your Advanced Skin Cancer Screening (ASCS) data to OHSU’s research efforts. The collaboration’s goal is to collect data from over 100,000 consenting recipients of ASCSs in a groundbreaking effort focused on early detection of skin cancer to improve survival rates. Start with a Full Body Imaging screening and if you do not need Dermoscopy, routine follow-up for a year! Our Dermogrpahers will tell you if they find any need for Dermoscopy. You can decide to see your local Dermatologist or get the ASCS. SUBSCRIBE NOW
Way better than free skin cancer screening!
Ready to find out more?
Sign up for our newsletter and we will email you when we are in your area.
We Help Find It Early
DermDetect is revolutionizing the way skin cancer is detected in America. We combine state of the art technology and expert dermatology to accurately image, analyze, store, identify, and review irregularities of the skin. We help find melanoma, basal cell, and squamous cell carcinoma at their earliest stages, the key factor to improve outcomes.
Am I at risk of skin cancer?
Find out here by taking this easy quiz provided by the Skin Cancer Foundation
Melanoma Risk Predictor
The Melanoma Risk Predictor is not intended to be used as a substitute for your doctor's advice. You should always consult your doctor if you think you might be at risk, particularly if you have noticed a new or changed skin lesion.
ASCS applauds the researchers in Queensland. The Health History Questionnaire you complete with the ASCS may allow researchers in the USA to develop these type of useful tools. Our research will result in a first-ever database that includes DICOM ELM and clinical images, pathology results and participant's health history and risk factors.